References
- Attwood M. R, Francis R. J, Hassall C. H, Krühn A., Lawton G., Natoff I. L, Nixon J. S, Redshaw S., Thomas W. A. New potent inhibitors of angiotensin converting enzyme. FEBS Letters 1984; 165: 201–206
- Natoff I. L, Nixon J. S, Francis R. J, Klevans L. R, Brewster M., Budd J., Patel A. T, Wenger J., Worth E. Biological properties of the angiotensin-converting enzyme inhibitor cilazapril. J. Cardiovasc. Pharmacol. 1985; 7: 569–580
- Hoick M., Fischli W., Hefti F., Gerold M. Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs. J. Cardiovasc. Pharmacol. 1986; 8: 99–108
- Miyazaki M., Okutiishi H., Nishimura K., Toda N. Vascular angiotensin-converting enzyme activity in man and other species. Clin. Sci. 1984; 66: 39–45
- Rothenthal J. H, Pfeifle B., Michailov M. L, Psychorr J., Jacob I. C.M., Dahlheim H. Investigations of components of the renin-angiotensin system in rat vascular tissue. Hypertension 1984; 6: 383–390
- Mizuno K., Hata S., Fukuchi S. Effect of sodium intake on angiotensin-converting enzyme activity of aorta in rats. Clin. Sci. 1981; 61: 249–251